Conference Overview
Organisers:
-
Risto Kauppinen (University of Bristol, Chair
-
Elizabeth Coulthard (University of Bristol)
-
Roy Jones (University of Bath)
-
Richard Wise (Cardiff University)
-
Dennis Chan (University of Cambridge)
The non-invasive imaging modalities, MRI and MRS, are increasingly used both in basic and clinical research of dementia. The ongoing international efforts of the ADNI and its European counterpart have greatly advanced translations of MRI and MRS into clinical dementia trials and patient care during the past decade. The time is right to communicate both the recent developments in MRI and MRS technologies and the most recent imaging findings to the audience of dementia researchers and healthcare professionals with a view to further the exploitation of imaging in early detection of pathology in subjects with imminent dementia.
The objectives of the conference are summarised as follows:
-
To present the state-of-the-art volumetric MRI techniques and their role in dementia diagnosis and treatment monitoring
-
To present novel MRI techniques that allow imaging of brain tissue microstructure and highlight the utility of these techniques in detection of early dementia pathology
-
To communicate developments and promises of ultra-high field MRI in dementia imaging
-
To communicate potentials of advanced MRI and MRS to reveal pathology before macroscopic volume change as means to detect imminent dementia
-
To promote interaction of MR and dementia scientists in the UK for efficient utilisation of MRI and MRS in translational dementia research
Conference speakers
*David Alsop (Harvard University, Boston, MA, USA); *Elizabeth Coulthard (University of Bristol); *Eugene Duff (University of Oxford); *Nick Fox (UCL, London); *Kim Graham (Cardiff University); *Roger Gunn (Imperial College London); *Mark Jenkinson (University of Oxford); *Risto Kauppinen (University of Bristol); *Michael Knight (University of Bristol); Mark Lythgoe (UCL, London); *Seth Love (University of Bristol); *Hugh Markus (University of Cambridge); *Gulin Oz, (CMRR, Minneapolis, USA); *Erlend Nagelhus (University of Oslo, Norway); Hilkka Soininen (University of Eastern Finland, Kuopio, Finland); *Nick Weiskopf (UCL and Max Planck Institute, Leipzig, Germany); *Laura Wisse (University Medical Center, Utrecht, The Netherlands); *Annalena Venneri (University of Sheffield).
*confirmed
